Shrinking the Manufacturing Footprint with PET Point-of-Care

Shrinking the Manufacturing Footprint with PET Point-of-Care “Today, most PET radiopharmaceuticals are produced at centralized locations and distributed. However, there are logistical limitations to this model and that is why it becomes increasingly interesting, and perhaps important, to consider point-of-care manufacturing.”  – Jared Driskill, Senior Medical Advisor at MedTrace, in the January 2024 edition of […]

The first scientific article based on a MedTrace-sponsored study has been published

The first scientific article based on a MedTrace-sponsored study has been published MedTrace is proud to see the methodology paper “Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW” published in Journal of Nuclear Cardiology (2024) vol. 31. The article is authored, […]

MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023

MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023 MedTrace is showcasing its technology and Phase 3 Clinical Trial at ASNC2023, The American Society of Nuclear Cardiology’s annual conference, taking place in Toronto, Ontario, Canada from September 29 through October 1.   This year, MedTrace is also sponsoring the Women in Nuclear Cardiology […]

MedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial

MedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial The Danish pharmaceutical and medical device company MedTrace has just closed an investment round of 18.2 million euros, overperforming its target of raising 15 million. In a challenging capital market, the investors have reaffirmed their confidence in MedTrace’s goal of making […]

15O-water demonstrations at EANM’23: Experience the daily preparation and setup of MedTrace’s 15O-water automated manufacturing system

15O-water demonstrations at EANM’23: Experience the daily preparation and setup of MedTrace’s 15O-water automated manufacturing system When The Annual European Association of Nuclear Medicine Congress opens in Vienna on September 9, 2023, MedTrace is on the spot and ready to showcase its technology and present the latest from its ongoing Phase 3 Clinical Trial RAPID-WATER-FLOW. […]

MedTrace hosts 15O-water symposium for nuclear medicine professionals

MedTrace hosts 15O-water symposium for nuclear medicine professionals 15O-water: Ready for the Future. Vol. 2. The symposium, sponsored by MedTrace, will take place on September 11, 2023, in Vienna. Guests can expect to hear from some of the world’s leading experts when they present new research and share their first-hand experiences with 15O-water. MedTrace is […]

MedTrace expands patent portfolio and protects its 15O-water technology

MedTrace expands patent portfolio and protects its 15O-water technology The U.S. Patent and Trademark Office has confirmed that MedTrace’s way of producing and dosing small volumes of 15O-water with high precision to patients before a PET scan is unique, consequently granting MedTrace a patent. The new patent is a testament to the company’s impressive innovation […]